AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $131,868 | +16.7% | 10,800 | 0.0% | 0.06% | 0.0% |
| Q3 2022 | $113,000 | -7.4% | 10,800 | -5.3% | 0.06% | 0.0% |
| Q2 2022 | $122,000 | +18.4% | 11,400 | -3.8% | 0.06% | +38.1% |
| Q1 2022 | $103,000 | -1.0% | 11,850 | +9.2% | 0.04% | -4.5% |
| Q3 2021 | $104,000 | +5.1% | 10,850 | +6.4% | 0.04% | -30.2% |
| Q4 2019 | $99,000 | -26.7% | 10,200 | 0.0% | 0.06% | -32.3% |
| Q2 2019 | $135,000 | -18.7% | 10,200 | -16.4% | 0.09% | -13.1% |
| Q1 2019 | $166,000 | +39.5% | 12,200 | -1.6% | 0.11% | +18.9% |
| Q4 2018 | $119,000 | -9.8% | 12,400 | +13.8% | 0.09% | +8.4% |
| Q3 2018 | $132,000 | -17.0% | 10,900 | +6.9% | 0.08% | -25.2% |
| Q2 2018 | $159,000 | -1.2% | 10,200 | -4.7% | 0.11% | -2.6% |
| Q1 2018 | $161,000 | 0.0% | 10,700 | -4.5% | 0.11% | +9.6% |
| Q4 2017 | $161,000 | +4.5% | 11,200 | +9.8% | 0.10% | -3.7% |
| Q3 2017 | $154,000 | – | 10,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |